A prospective, multi-centre, observational study to examine kidney disease progression in adults with chronic kidney disease – CKDOD - Study design and preliminary resultsReport as inadecuate




A prospective, multi-centre, observational study to examine kidney disease progression in adults with chronic kidney disease – CKDOD - Study design and preliminary results - Download this document for free, or read online. Document in PDF available to download.

BMC Nephrology

, 16:215

First Online: 22 December 2015Received: 15 May 2015Accepted: 24 November 2015

Abstract

BackgroundThe objective of this article is to describe the organisation of an international, clinical registry, the Chronic Kidney Disease Observational Database CKDOD, the processes of enrolling patients and entering data and preliminary results to date.

DesignThe Chronic Kidney Disease Observational Database CKDOD is designed to assess the association between different factors with a known influence on chronic kidney disease CKD progression as well as treatment strategies such as dietary modifications, blood pressure control and pharmacological interventions in Asian countries India, China, Malaysia and Thailand. The only inclusion criterion is the presence of CKD stage 2 or higher as defined by the KDIGO guidelines. Demographic and clinical information are collected by a standardised electronic questionnaire, available in English and Chinese. The data are transferred to the CKDOD database either by e-mail or via web access. All data are checked for consistency and missing values.

Collection of data started in September 2011 and by April 2015, data on 1323 individual patients had been submitted. The mean age at inclusion was 57 ± 14 years, 67 % were male and 36 % were diabetic. The baseline estimated glomerular filtration rate was 26 ml-min-1.73 m. Of all enrolled patients, 324 24 % received ketoanalogue supplementation during at least one recorded visit.

DiscussionThe CKDOD is a very large and comprehensive data repository, currently focused in subjects recruited from Asia. The database is expected to provide important long-term information on CKD progression, nutritional and metabolic derangements that accompany CKD progression and treatment strategies to ameliorate progression and complications of CKD.

Trial RegistrationClinical Trial Registry – India: CTRI-2012-06-002743; 25th July 2012

KeywordsChronic kidney disease Clinical registry Ketoanalogue supplementation AbbreviationsCDKDClinical Database of Kidney Diseases

CKDChronic kidney disease

CKDODChronic Kidney Disease Observational Database

ESRDEnd-stage renal disease

Electronic supplementary materialThe online version of this article doi:10.1186-s12882-015-0191-5 contains supplementary material, which is available to authorized users.

Download fulltext PDF



Author: Bharat Shah - Ashok Kirpalani - Sham Sunder - Ashwani Gupta - Umesh Khanna - Deodatta Chafekar - Li Ping Tan - Dhavee Sir

Source: https://link.springer.com/







Related documents